Search research articles
Contact Us
Filters
Showing results (131-140 of 216) with videos related to
Page
of 22
Sort By:
The Journal of Experimental Medicine
|
November 25, 2024
Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer
Camila Robles-Oteíza, Katherine Hastings, Jungmin Choi, et al.
Biorxiv : the Preprint Server for Biology
|
April 3, 2026
Mutant p53 Directs PARP to Regulate Replication Stress and Drive Breast Cancer Metastasis
Gu Xiao, George K Annor, Katherine W Harmon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2024
Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways
Mario E Lacouture, Elena Goleva, Neil Shah, et al.
Cancer Immunology Research
|
September 30, 2016
Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells
Elliott J Brea, Claire Y Oh, Eusebio Manchado, et al.
Cancer Research
|
March 1, 2014
Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence
Moriah H Nissan, Christine A Pratilas, Alexis M Jones, et al.
Cancer Cell
|
August 8, 2025
CHI3L3<sup>+</sup> immature neutrophils inhibit anti-tumor immunity and impede immune checkpoint blockade therapy in bone metastases
Tao Shi, Wei Liu, Yuting Luo, et al.
Nature Immunology
|
February 19, 2020
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors
Haiping Wang, Fabien Franco, Yao-Chen Tsui, et al.
Cell Reports. Medicine
|
November 2, 2024
Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma
Michelangelo Marasco, Dinesh Kumar, Tessa Seale, et al.
Scientific Reports
|
December 1, 2021
In vivo optical imaging-guided targeted sampling for precise diagnosis and molecular pathology
Aditi Sahu, Yuna Oh, Gary Peterson, et al.
Nature
|
February 21, 2020
ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
John Alec Moral, Joanne Leung, Luis A Rojas, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 216) with videos related to
Sort By:
Page
of 22
The Journal of Experimental Medicine
|
November 25, 2024
Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer
Camila Robles-Oteíza, Katherine Hastings, Jungmin Choi, et al.
Biorxiv : the Preprint Server for Biology
|
April 3, 2026
Mutant p53 Directs PARP to Regulate Replication Stress and Drive Breast Cancer Metastasis
Gu Xiao, George K Annor, Katherine W Harmon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2024
Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways
Mario E Lacouture, Elena Goleva, Neil Shah, et al.
Cancer Immunology Research
|
September 30, 2016
Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells
Elliott J Brea, Claire Y Oh, Eusebio Manchado, et al.
Cancer Research
|
March 1, 2014
Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence
Moriah H Nissan, Christine A Pratilas, Alexis M Jones, et al.
Cancer Cell
|
August 8, 2025
CHI3L3<sup>+</sup> immature neutrophils inhibit anti-tumor immunity and impede immune checkpoint blockade therapy in bone metastases
Tao Shi, Wei Liu, Yuting Luo, et al.
Nature Immunology
|
February 19, 2020
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors
Haiping Wang, Fabien Franco, Yao-Chen Tsui, et al.
Cell Reports. Medicine
|
November 2, 2024
Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma
Michelangelo Marasco, Dinesh Kumar, Tessa Seale, et al.
Scientific Reports
|
December 1, 2021
In vivo optical imaging-guided targeted sampling for precise diagnosis and molecular pathology
Aditi Sahu, Yuna Oh, Gary Peterson, et al.
Nature
|
February 21, 2020
ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
John Alec Moral, Joanne Leung, Luis A Rojas, et al.
Page
of 22